Skip to content

Verification of the effects of continuous intake of the test food on visceral fat

A randomized, double-blind, placebo-controlled, parallel-group comparative study on the effect of continuous intake of the test food on visceral fat in healthy adult men and women - A randomized, double-blind, placebo-controlled, parallel-group comparative study on the effect of continuous intake of the test food on visceral fat in healthy adult men and women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052958
Enrollment
60
Registered
2023-12-01
Start date
2023-12-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy adult men and women

Interventions

Sponsors

BHN Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Japanese men and women aged between 20 and 60 at the time of obtaining written consent 2) Persons with a BMI of 23 or more and less than 30 3) Subjects who have received a sufficient explanation of the purpose and content of the research, are capable of giving consent, have fully understood the study, voluntarily applied to participate in the study, and agreed to participate in the study in writing.

Exclusion criteria

Exclusion criteria: 1.individuals using medical products. 2.existing or past illnesses such as skin diseases 3.who are likely to exhibit severe allergic symptoms to test foods or metals. 4.Who have taken drugs such as fat absorption inhibitors or appetite suppressants that affect body weight and body fat, drugs related to obesity improvement, performed any treatment for slimming purposes, or used quasi-drugs ,those who have taken food for specified health uses, health foods or supplements in the past 1 months 5.severe anemia 6. Currently pregnant or breastfeeding. Or those who may be affected during the exam period. 7. Who have Serious diseases such as liver, kidney, and heart diseases, 8.who are currently suffering from any serious or chronic disease and are undergoing medication treatment, outpatient treatment, diet therapy, or exercise therapy. 9.using health foods, supplements, or medicines that may affect test results 10.current disease or history of drug dependence or alcohol dependence 11.who are currently hospitalized for mental disorders (depression, etc.), sleep disorders, etc., or who have a history of mental disorders in the past. 12.whose daily rhythms are irregular due to night work or shift work, etc. 13.whose lifestyle may change from the pre-test to the test period 14.extremely irregular lifestyle habits such as eating and sleeping 15.who have extreme picky eating habits. 16.who participated in other clinical studies in the past 3 months to the date of consent acquisition, or those who plan to participate in other clinical trials (research) during the study period. 17.who donated blood over 200mL in the past 1 month or over 400mL in the past 3 months. 18.who have difficulty completing records on various survey forms 19. Persons judged to be unsuitable as subjects based on clinical test values and measured values at the time of SCR 20. Any other person deemed unsuitable as a subject by the principal investigator.

Design outcomes

Primary

MeasureTime frame
visceral fat area

Secondary

MeasureTime frame
Weight, BMI, waist circumference, hip circumference

Countries

Japan

Contacts

Public ContactDaisuke Ochitani

BHN Co., Ltd EBF

d-ochitani@bhn.co.jp03-5281-5661

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026